ZEALAND PHARMA A/S
DEAD

Serial Number

77829889

Owner

ZEALAND PHARMA A/S

Attorney

Thomas A. Polcyn

Filing Date

Sep 18, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ZEALAND PHARMA A/S Trademark

Serial Number: 77829889

ZEALAND PHARMA A/S is a trademark filed by ZEALAND PHARMA A/S on September 18, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ZEALAND PHARMA A/S (41 trademarks)

SØBORG 2860 , DK

Entity Type: 03

Trademark Details

Filing Date

September 18, 2009

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; synthetic peptides for pharmaceutical purposes

Exploitation of scientific research and technology, namely, promoting collaboration and the exchange of information and resources within the scientific, research and medical communities to achieve advances in the field of health care

Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; dentistry services; medical analysis for the diagnosis and treatment of persons; pharmaceutical advice

Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; design and development of computer hardware and software; medical, biological, biotechnological, genetic and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 31, 2011 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 31, 2011 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 21, 2011 GNFN
FINAL REFUSAL E-MAILED
Mar 21, 2011 GNFR
FINAL REFUSAL WRITTEN
Mar 21, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 18, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2010 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2010 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2010 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 12, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 16, 2010 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 7, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2010 CRFA
ASSIGNED TO LIE
Jun 2, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 26, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 26, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 26, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2009 NWOS
NEW APPLICATION ENTERED
Sep 22, 2009 NWAP